e-learning
resources
Paris 2018
Monday, 17.09.2018
Predicting the future: biomarkers of respiratory infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
E. Wittermans (Nieuwegein, Netherlands), S. Vestjens (Nieuwegein, Netherlands), W. Bos (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands), E. Van De Garde (Nieuwegein, Netherlands), B. Vlaminckx (Nieuwegein, Netherlands)
Source:
International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Session:
Predicting the future: biomarkers of respiratory infection
Session type:
Thematic Poster
Number:
2614
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Wittermans (Nieuwegein, Netherlands), S. Vestjens (Nieuwegein, Netherlands), W. Bos (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands), E. Van De Garde (Nieuwegein, Netherlands), B. Vlaminckx (Nieuwegein, Netherlands). The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.. 2614
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study.
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018
Year: 2018
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives
Source: Eur Respir J 2004; 24: Suppl. 48, 185s
Year: 2004
Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study
Source: Eur Respir J, 54 (1) 1900057; 10.1183/13993003.00057-2019
Year: 2019
Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Comparative prospective cohort study of the efficacy and safety according to dose of Ceftriaxone in community-acquired pneumonia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
The impact of blood glucose on community-acquired pneumonia: a retrospective cohort study
Source: ERJ Open Res, 3 (2) 00114-2016; 10.1183/23120541.00114-2016
Year: 2017
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity
Source: Eur Respir J 2006; 28: Suppl. 50, 530s
Year: 2006
Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia.
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Year: 2018
Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Recovery in adults hospitalised with community-acquired pneumonia; a systematic review and meta-analysis
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
GRACE-01 Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe – a multicentre, observational cohort study of cough/LRTI in primary care
Source: Annual Congress 2007 - Clinical trial: antibiotic use in the community
Year: 2007
A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept